Most pregnancy-related infections are caused by four treatable conditions – In low-and-middle income countries, pregnancy-related infections are a major cause of maternal death, can also be fatal to unborn and newborn babies, and are mostly caused by four types of conditions that are treatable and preventable, according to a review by US researchers published in this week’s PLOS Medicine.
Low-level mercury exposure in pregnant women connected to ADHD risk in children — Researchers advise women to consider both benefits and risks of eating fish while pregnant – ADHD or Attention-deficit/hyperactivity disorder affects approximately ten percent of children worldwide, yet its causes are not well understood. Now, a study led by Susan Korrick, MD, MPH, of Brigham and Women’s Hospital (BWH), and Sharon Sagiv, PhD, MPH, of Boston University School of Public Health, and published in the Archives of Pediatrics & Adolescent Medicine, links low-level prenatal mercury exposure with a greater risk of ADHD-related behaviors.
FDA takes action against thousands of illegal Internet pharmacies — Agency participates in international Operation Pangea V to protect consumers from potentially dangerous, unapproved drugs – The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action this week against more than 4,100 Internet pharmacies that illegally sell potentially dangerous, unapproved drugs to consumers. Actions taken include civil and criminal charges, seizure of illegal products, and removal of offending websites.
Low birth weight may increase risk for cardiovascular disease, kidney disease and diabetes — New research in The FASEB Journal suggests that poor high blood pressure management during pregnancy may have negative long-term health consequences for offspring – Being underweight at birth may have consequences above and beyond the known short-term effects says a research report. The report shows that rats with a low birth weight have an increased long-term risk for developing cardiovascular disease, kidney disease, and diabetes.
No evidence that drug used for preventing life-threatening bleeding in women during labor works — Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage – There is insufficient evidence for the effectiveness of a drug that is being used increasingly to prevent life-threatening bleeding in women after giving birth in community settings in low income countries.
U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management – The U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management.
IUDs, implants most effective birth control – Women who used birth control pills, the patch or vaginal ring were 20 times more likely to have an unintended pregnancy than those who used longer-acting forms such as an intrauterine device (IUD) or implant.
Flu shot during pregnancy shows unexpected benefits in large study – Getting a flu shot during pregnancy provides unanticipated benefits to the baby. A new study showed that H1N1 vaccination during the pandemic was associated with a significantly reduced risk of stillbirth, preterm birth and extremely small babies at birth.
Family preferences strongly influence decision making in very premature deliveries — Wide variation in practices and counseling reported in the American Journal of Obstetrics and Gynecology – When making decisions and counseling about risk and management options for deliveries between 22 and 26 weeks (periviable deliveries), obstetricians are heavily influenced by family preferences, particularly by the impression that parents consistently prefer to have everything possible done to prolong a pregnancy or “save the baby” through interventions such as cesarean section.
Pfizer Announces Voluntary Nationwide Recall Of Lo/Ovral?-28 And Norgestrel/Ethinyl Estradiol Tablets Due To Possibility Of Inexact Tablet Counts Or Out Of Sequence Tablets – Pfizer Inc. announced that it has voluntarily recalled 14 lots of Lo/Ovral?-28 (norgestrel and ethinyl estradiol)Tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic)for customers in the U.S. market.
